Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial)

Table 3 Time to event (months) progression free and disease specific survival

Patient Number	Treatment Stopped	PFS	OS	Cause of death	Last known alive
A1	1.2	1.2			15.8
A2	Did not start	0.2			11.7
A3	Did not start^a				0.0¹
B1	0.8				14.1
B2	9.4	9.2			10.2
C1	0.5				0.5
C2	4.2	4.1	9.4	Disease related
C3	1.7	1.5	4.6	Disease related

ISSN: 1471-2407